New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 3, 2012
12:45 EDTMELAMELA Sciences named best idea at Stephens
Stephens made MELA Sciences its best idea after channel checks indicated early launch of the company's MelaFind technology is progressing very well. Stephens believes MELA shares are pricing in little chance of commercial success and sees minimal downside at current levels. The firm keeps an Overweight rating on the stock with a $10 price target.
News For MELA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 23, 2015
09:14 EDTMELAOn The Fly: Pre-market Movers
Subscribe for More Information
08:43 EDTMELAMELA Sciences to host business news update conference call
Conference call to be held on June 23 at 8:30 am. Webcast Link
08:07 EDTMELAMELA Sciences acquires XTRAC, VTRAC business from PhotoMedex for $42.5M
MELA Sciences announced that it has signed and completed the purchase of the XTRAC and VTRAC Dermatology business from PhotoMedex, Inc. for $42.5M in cash and the assumption of certain business-related liabilities. The purchase price includes all of the accounts receivable, inventory and fixed and intangible assets of the businesses. To fund the purchase price of the transaction, the company has issued senior secured notes and convertible debentures equal to the transaction purchase price to certain investors. The XTRAC and VTRAC businesses generated $30.6M in revenues in 2014.
08:05 EDTMELAPhotoMedex sells XTRAC, VTRAC businesses to MELA for $42.5M in cash
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use